Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Polonsky

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
International Journal of General Medicine|July 16, 2024
Recommendations for Screening and Monitoring the Stages of Type 1 Diabetes in the Immune Therapy EraDaniel J Moore, Natasha I Leibel, William Polonsky, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 20, 2024
A novel approach to understanding and assessing the emotional side of type 1 diabetes: The Type 1-Diabetes Distress Assessment SystemLawrence Fisher, William Polonsky, Diana Naranjo, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|June 21, 2021
Exploring Why People With Type 2 Diabetes Do or Do Not Persist With Glucagon-Like Peptide-1 Receptor Agonist Therapy: A Qualitative StudyWilliam Polonsky, Cory Gamble, Neeraj Iyer, et al.
Journal of Diabetes and Its Complications|October 16, 2020
The early impact of the COVID-19 pandemic on adults with type 1 or type 2 diabetes: A national cohort studyLawrence Fisher, William Polonsky, Adijat Asuni, et al.
Patient Education and Counseling|April 7, 2019
Toward effective interventions to reduce diabetes distress among adults with type 1 diabetes: Enhancing Emotion regulation and cognitive skillsLawrence Fisher, Danielle Hessler, William Polonsky, et al.
Journal of Diabetes and Its Complications|April 28, 2016
Diabetes distress in adults with type 1 diabetes: Prevalence, incidence and change over timeLawrence Fisher, Danielle Hessler, William Polonsky, et al.
Journal of Diabetes and Its Complications|January 2, 2017
Improved treatment satisfaction in patients with type 1 diabetes treated with insulin glargine 100U/mL versus neutral protamine Hagedorn insulin: An exploration of key predictors from two randomized controlled trialsWilliam Polonsky, Louise Traylor, Ling Gao, et al.
Diabetes, Obesity & Metabolism|November 15, 2021
Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature reviewMarc Evans, Susanne Engberg, Mads Faurby, et al.
BMC Primary Care|April 22, 2024
Understanding suboptimal insulin use in type 1 and 2 diabetes: a cross-sectional survey of healthcare providers who treat people with diabetesRachel S Newson, Erik Spaepen, Birong Liao, et al.
Patient Education and Counseling|July 26, 2017
Emotion regulation contributes to the development of diabetes distress among adults with type 1 diabetesLawrence Fisher, Danielle Hessler, William Polonsky, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
International Journal of General Medicine|July 16, 2024
Recommendations for Screening and Monitoring the Stages of Type 1 Diabetes in the Immune Therapy EraDaniel J Moore, Natasha I Leibel, William Polonsky, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 20, 2024
A novel approach to understanding and assessing the emotional side of type 1 diabetes: The Type 1-Diabetes Distress Assessment SystemLawrence Fisher, William Polonsky, Diana Naranjo, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|June 21, 2021
Exploring Why People With Type 2 Diabetes Do or Do Not Persist With Glucagon-Like Peptide-1 Receptor Agonist Therapy: A Qualitative StudyWilliam Polonsky, Cory Gamble, Neeraj Iyer, et al.
Journal of Diabetes and Its Complications|October 16, 2020
The early impact of the COVID-19 pandemic on adults with type 1 or type 2 diabetes: A national cohort studyLawrence Fisher, William Polonsky, Adijat Asuni, et al.
Patient Education and Counseling|April 7, 2019
Toward effective interventions to reduce diabetes distress among adults with type 1 diabetes: Enhancing Emotion regulation and cognitive skillsLawrence Fisher, Danielle Hessler, William Polonsky, et al.
Journal of Diabetes and Its Complications|April 28, 2016
Diabetes distress in adults with type 1 diabetes: Prevalence, incidence and change over timeLawrence Fisher, Danielle Hessler, William Polonsky, et al.
Journal of Diabetes and Its Complications|January 2, 2017
Improved treatment satisfaction in patients with type 1 diabetes treated with insulin glargine 100U/mL versus neutral protamine Hagedorn insulin: An exploration of key predictors from two randomized controlled trialsWilliam Polonsky, Louise Traylor, Ling Gao, et al.
Diabetes, Obesity & Metabolism|November 15, 2021
Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature reviewMarc Evans, Susanne Engberg, Mads Faurby, et al.
BMC Primary Care|April 22, 2024
Understanding suboptimal insulin use in type 1 and 2 diabetes: a cross-sectional survey of healthcare providers who treat people with diabetesRachel S Newson, Erik Spaepen, Birong Liao, et al.
Patient Education and Counseling|July 26, 2017
Emotion regulation contributes to the development of diabetes distress among adults with type 1 diabetesLawrence Fisher, Danielle Hessler, William Polonsky, et al.
Pageof 5